HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The effect of prophylactic nicorandil infusion to reduce intraoperative myocardial ischemia during abdominal surgery in patients with risk factors of ischemic heart disease].

Abstract
Three hundred patients who had undergone abdominal surgery with risk factors of ischemic heart disease (IHD), such as hypertension, diabetes mellitus, hyperlipidemia, smoking, advanced age, obesity, familial history, electrocardiographic abnormality, other perivascular disease, and male, were included in this study. Patients older than forty years were included in the study. They were divided into two groups for a randomized double blind trial: nicorandil was administered in one group (group N) and placebo in another (group C), and we investigated the effect of prophylactic nicorandil infusion to reduce intraoperative myocardial ischemia. ST segment in leads II and Vs was recorded by ST trend monitor from the time of patient's entering the operating room to the time to exit. Intraoperative myocardial ischemia occurred in 11 patients in group N and in 32 patients in group C (P < 0.0001). Prophylactic nicorandil infusion was effective to reduce intraoperative myocardial ischemia in patients with risk factors of IHD during abdominal surgery.
AuthorsT Kaneko, M Hayashida, Y Saito, Y Hikawa, K Yasuda
JournalMasui. The Japanese journal of anesthesiology (Masui) Vol. 49 Issue 1 Pg. 54-9 (Jan 2000) ISSN: 0021-4892 [Print] Japan
PMID10689845 (Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Vasodilator Agents
  • Nicorandil
Topics
  • Abdomen (surgery)
  • Adult
  • Double-Blind Method
  • Electrocardiography
  • Female
  • Humans
  • Intraoperative Care
  • Intraoperative Complications (diagnosis, prevention & control)
  • Male
  • Middle Aged
  • Monitoring, Intraoperative
  • Myocardial Ischemia (diagnosis, prevention & control)
  • Nicorandil (administration & dosage)
  • Risk Factors
  • Vasodilator Agents (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: